These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Drug therapy and therapeutic tactics in gastroduodenal ulcer]. Grigor'ev PIa; Isakov VA; Iakovenko EP Ter Arkh; 1988; 60(8):118-26. PubMed ID: 2906485 [No Abstract] [Full Text] [Related]
3. [H2 blockers and acute peptic ulcer]. Müller P; Dammann HG; Simon B Fortschr Med; 1986 Dec; 104(3):903-7. PubMed ID: 2881861 [No Abstract] [Full Text] [Related]
4. [Mechanism of action and therapeutic effectiveness of histamine H2 receptor blockaders in peptic ulcer]. Glubochenko VG; Shcherbak VV Vrach Delo; 1985 Feb; (2):13-5. PubMed ID: 2859701 [No Abstract] [Full Text] [Related]
5. [Therapy of peptic ulcer. H2 receptor blockers]. Domschke W Verh Dtsch Ges Inn Med; 1988; 94():272-5. PubMed ID: 2905101 [No Abstract] [Full Text] [Related]
6. Clinical relevance of tolerance to peptic ulcer healing and relapse. Misiewicz JJ Aliment Pharmacol Ther; 1990; 4 Suppl 1():85-96. PubMed ID: 1983350 [No Abstract] [Full Text] [Related]
7. Drug therapy of peptic ulcer disease. Ching CK; Lam SK Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483 [TBL] [Abstract][Full Text] [Related]
8. [What is the role of H2 receptor blockers today in ulcer therapy?]. Creutzfeldt W Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690 [No Abstract] [Full Text] [Related]
9. [Follow-up studies of the tissue healing process in peptic ulcer; clinicopathological study of recurrence refractory conditions in peptic ulcer]. Saito Y; Kato T; Niwa M; Ogoshi K; Tsunoda H Nihon Rinsho; 1988 Jan; 46(1):94-7. PubMed ID: 2897488 [No Abstract] [Full Text] [Related]
10. [Pro conservative long-term therapy of peptic ulcer]. Arnold R Z Gastroenterol; 1984 Apr; 22(4):195-7. PubMed ID: 6145261 [No Abstract] [Full Text] [Related]
11. [Conservative long-term therapy of peptic ulcer--pro and con]. Rösch W Z Gastroenterol; 1984 Apr; 22(4):194. PubMed ID: 6145260 [No Abstract] [Full Text] [Related]
12. [Current viewpoints in the pathogenesis and therapy of peptic ulcer]. Tytgat GN Ned Tijdschr Geneeskd; 1987 Oct; 131(41):1799-802. PubMed ID: 2890110 [No Abstract] [Full Text] [Related]
13. [Treatment of peptic ulcer with histamine H2-receptor antagonists]. Radbil' OS Sov Med; 1977 Nov; (11):111-9. PubMed ID: 24276 [No Abstract] [Full Text] [Related]
14. [Current concepts of the treatment of patients with peptic ulcer]. Miagkova LP Klin Med (Mosk); 1991 Sep; 69(9):113-8. PubMed ID: 1687074 [No Abstract] [Full Text] [Related]
15. [Peptic ulcer: changing indications for gastric resection during the last 15 years]. Della Beffa V; Carelli-Basile A; Leli R; Fontana D Minerva Chir; 1994 Nov; 49(11):1065-9. PubMed ID: 7708225 [TBL] [Abstract][Full Text] [Related]
16. [The effectiveness of plasmapheresis in treating long-term nonhealing gastroduodenal ulcers]. Iakhnina EI; Savchenko VG; Voronova GA Ter Arkh; 1990; 62(7):114-20. PubMed ID: 1979188 [TBL] [Abstract][Full Text] [Related]
18. Satellite symposium: New therapeutic approach to peptic ulcer disease. 34th annual meeting of the Japanese Society of Gastroenterology. Gastroenterol Jpn; 1993 May; 28 Suppl 5():191-201. PubMed ID: 8103024 [No Abstract] [Full Text] [Related]
19. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases (2). Feldman M; Burton ME N Engl J Med; 1990 Dec; 323(25):1749-55. PubMed ID: 1978926 [No Abstract] [Full Text] [Related]